Consumers will now be able to purchase an over-the-counter test to screen for genetic variants that may influence medication metabolism, the FDA has announced.
The direct-to-consumer test from 23andMe...
Duke University Pratt School of Engineering has established a new big data analytics center that will support global research to advance precision medicine.
Launched last month, the Sherry and John...
Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from...
Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences.
The project will...
The HHS Health Resources and Services Administration (HRSA) has awarded $21 million to 46 community health centers to support their participation in NIH’s All of Us precision medicine research...
The combination of machine learning tools and genomic data can help predict the risk of abdominal aortic aneurysm (AAA), one of the most frequently fatal heart conditions - and one that is most often...
Researchers from Boston University School of Medicine, in collaboration with scientists from the Alzheimer’s Disease Sequencing Project (ADSP), have discovered new genes that could contribute to...
Georgetown Lombardi Comprehensive Cancer Center will now make its collection of brain cancer data freely available to precision medicine researchers worldwide.
The dataset, called the REpository for...
Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic...
The Department of Veteran Affairs (VA) and IBM Watson Health have announced an extension of their partnership to bring artificial intelligence and genomic analytics to cancer care.
The VA’s...
The University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have announced the creation of the UPMC Genome Center, an advanced genome sequencing facility that will enhance...
The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology,...
Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care.
The incredibly complex nature of cancer, coupled with its many...
New guidance from the FDA urges drug development stakeholders to be transparent with their data as a way to maintain high quality and foster patient-centered precision medicine.
Innovative,...
Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients...
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has released results from several sub-studies that could...
Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope...
Precision medicine, big data analytics, and stakeholder collaboration could improve treatment and prevention of Alzheimer’s disease and related dementias, according to recommendations from the...
Cleveland Clinic and Brooks Automation have announced a new biobank facility to enhance research on human tissue samples and improve clinical care for several conditions, including cancer, heart...
The Harvard Business School Kraft Precision Medicine Accelerator has announced that five leading cancer organizations will come together to share best practices, engage patients, and create synergies...
